Reported Earnings • Apr 25
First quarter 2026 earnings released: EPS: CN¥0.085 (vs CN¥0.12 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.085 (down from CN¥0.12 in 1Q 2025). Revenue: CN¥6.09b (down 1.9% from 1Q 2025). Net income: CN¥717.4m (down 29% from 1Q 2025). Profit margin: 12% (down from 16% in 1Q 2025). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Announcement • Apr 25
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 15, 2026 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: Room 209, Office Building, Junzheng Changhe Huafu, Haida Junzheng Street, Binhe New District, Wuhai, Inner Mongolia China Announcement • Mar 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q1, 2026 Results on Apr 25, 2026 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026 Announcement • Dec 26
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.10 (vs CN¥0.086 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.10 (up from CN¥0.086 in 3Q 2024). Revenue: CN¥6.03b (down 10% from 3Q 2024). Net income: CN¥878.3m (up 21% from 3Q 2024). Profit margin: 15% (up from 11% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Announcement • Sep 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Reported Earnings • Aug 31
Second quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.095 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.095 in 2Q 2024). Revenue: CN¥6.45b (flat on 2Q 2024). Net income: CN¥912.6m (up 14% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Announcement • Jun 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Declared Dividend • Jun 01
Dividend reduced to CN¥0.15 Dividend of CN¥0.15 is 53% lower than last year. Ex-date: 6th June 2025 Payment date: 6th June 2025 Dividend yield will be 2.8%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (41% earnings payout ratio) but not covered by cash flows (212% cash payout ratio). The dividend has increased by an average of 31% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 21% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 27
Full year 2024 earnings released: EPS: CN¥0.33 (vs CN¥0.32 in FY 2023) Full year 2024 results: EPS: CN¥0.33 (up from CN¥0.32 in FY 2023). Revenue: CN¥25.2b (up 32% from FY 2023). Net income: CN¥2.80b (up 3.0% from FY 2023). Profit margin: 11% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Announcement • Apr 26
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 16, 2025 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: Room 209, Office Building, Junzheng Changhe Huafu, Haida Junzheng Street, Binhe New District, Wuhai, Inner Mongolia China Announcement • Mar 28
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥6.42, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 36x in the Chemicals industry in China. Total returns to shareholders of 50% over the past three years. Announcement • Dec 27
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Valuation Update With 7 Day Price Move • Dec 24
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥5.51, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 36x in the Chemicals industry in China. Total returns to shareholders of 23% over the past three years. New Risk • Dec 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 97% Paying a dividend despite having no free cash flows. Earnings have declined by 0.4% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Profit margins are more than 30% lower than last year (12% net profit margin). Buy Or Sell Opportunity • Dec 18
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 101% to CN¥7.24. The fair value is estimated to be CN¥5.98, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years. Earnings per share has declined by 24%. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥5.63, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 37x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Buy Or Sell Opportunity • Nov 25
Now 21% undervalued Over the last 90 days, the stock has risen 30% to CN¥4.65. The fair value is estimated to be CN¥5.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years. Earnings per share has declined by 24%. Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥4.94, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.077 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.086 (up from CN¥0.077 in 3Q 2023). Revenue: CN¥6.73b (up 55% from 3Q 2023). Net income: CN¥725.8m (up 11% from 3Q 2023). Profit margin: 11% (down from 15% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥4.18, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years. Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.095 (vs CN¥0.082 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.095 (up from CN¥0.082 in 2Q 2023). Revenue: CN¥6.46b (up 37% from 2Q 2023). Net income: CN¥801.5m (up 15% from 2Q 2023). Profit margin: 12% (down from 15% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Announcement • Jun 28
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Buy Or Sell Opportunity • Jun 06
Now 22% undervalued Over the last 90 days, the stock has risen 1.3% to CN¥3.96. The fair value is estimated to be CN¥5.09, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.2% over the last 3 years. Earnings per share has declined by 23%. Reported Earnings • Apr 27
First quarter 2024 earnings released: EPS: CN¥0.084 (vs CN¥0.098 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.084 (down from CN¥0.098 in 1Q 2023). Revenue: CN¥5.20b (up 2.0% from 1Q 2023). Net income: CN¥712.4m (down 14% from 1Q 2023). Profit margin: 14% (down from 16% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Announcement • Apr 27
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 16, 2024 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd., Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: Room 209, Office Building, Junzheng Changhe Huafu, Haida Junzheng Street, Binhe New District, Wuhai, Inner Mongolia China Announcement • Mar 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Announcement • Dec 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.077 (vs CN¥0.083 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.077 (down from CN¥0.083 in 3Q 2022). Revenue: CN¥4.34b (down 19% from 3Q 2022). Net income: CN¥651.3m (down 6.7% from 3Q 2022). Profit margin: 15% (up from 13% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings. Announcement • Sep 30
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023 Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: CN¥0.082 (vs CN¥0.14 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.082 (down from CN¥0.14 in 2Q 2022). Revenue: CN¥4.70b (down 17% from 2Q 2022). Net income: CN¥694.6m (down 40% from 2Q 2022). Profit margin: 15% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Announcement • Jun 28
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report First Half, 2023 Results on Aug 31, 2023 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report first half, 2023 results on Aug 31, 2023 Reported Earnings • Apr 28
Full year 2022 earnings released: EPS: CN¥0.49 (vs CN¥0.54 in FY 2021) Full year 2022 results: EPS: CN¥0.49 (down from CN¥0.54 in FY 2021). Revenue: CN¥21.5b (up 11% from FY 2021). Net income: CN¥4.16b (down 8.3% from FY 2021). Profit margin: 19% (down from 24% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 15% per year. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥4.65, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 85% over the past three years. Board Change • Nov 16
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. 3 independent directors (4 non-independent directors). Chairman of Board of Supervisors Jiang Bo Du is the most experienced director on the board, commencing their role in 2017. Independent Director Ti Xing Wang was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.083 (vs CN¥0.12 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.083 (down from CN¥0.12 in 3Q 2021). Revenue: CN¥5.35b (up 14% from 3Q 2021). Net income: CN¥698.2m (down 30% from 3Q 2021). Profit margin: 13% (down from 21% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 29
Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.13 in 2Q 2021). Revenue: CN¥5.66b (up 23% from 2Q 2021). Net income: CN¥1.15b (up 2.2% from 2Q 2021). Profit margin: 20% (down from 25% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥5.37, the stock trades at a trailing P/E ratio of 10.5x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 102% over the past three years. Reported Earnings • May 02
First quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.10 (down from CN¥0.13 in 1Q 2021). Revenue: CN¥4.80b (up 18% from 1Q 2021). Net income: CN¥877.9m (down 21% from 1Q 2021). Profit margin: 18% (down from 27% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Yin Ping Hao is the most experienced director on the board, commencing their role in 2020. Independent Director Ti Xing Wang was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 21
Full year 2021 earnings released: EPS: CN¥0.54 (vs CN¥0.57 in FY 2020) Full year 2021 results: EPS: CN¥0.54 (down from CN¥0.57 in FY 2020). Revenue: CN¥19.3b (up 30% from FY 2020). Net income: CN¥4.54b (down 5.8% from FY 2020). Profit margin: 24% (down from 33% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥5.72, the stock trades at a trailing P/E ratio of 8.4x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 128% over the past three years. Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥6.92, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 180% over the past three years. Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.082 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥4.60b (up 27% from 2Q 2020). Net income: CN¥1.13b (up 62% from 2Q 2020). Profit margin: 25% (up from 19% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 27
Full year 2020 earnings released: EPS CN¥0.57 (vs CN¥0.29 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.8b (up 51% from FY 2019). Net income: CN¥4.82b (up 93% from FY 2019). Profit margin: 33% (up from 25% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 23% share price gain to CN¥6.68, the stock is trading at a trailing P/E ratio of 21.4x, up from the previous P/E ratio of 17.4x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past year are 160%. Is New 90 Day High Low • Feb 22
New 90-day high: CN¥6.68 The company is up 19% from its price of CN¥5.63 on 24 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improved over the past week After last week's 30% share price gain to CN¥5.87, the stock is trading at a trailing P/E ratio of 18.8x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 128%. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥4.60 The company is down 39% from its price of CN¥7.56 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 08
New 90-day low: CN¥5.17 The company is down 29% from its price of CN¥7.32 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Nov 18
New 90-day low: CN¥5.73 The company is down 39% from its price of CN¥9.34 on 20 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥2.64b, up 12% from the prior year. Total revenue was CN¥14.1b over the last 12 months, up 64% from the prior year. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥7.03 The company is down 6.0% from its price of CN¥7.47 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.19 per share. Announcement • Oct 27
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report Q3, 2020 Results on Oct 30, 2020 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report Q3, 2020 results on Oct 30, 2020 Announcement • Sep 09
Chubb Tempest Reinsurance Limited completed the acquisition of an additional 15.3% stake in Huatai Insurance Group Co., Ltd. from Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd(SHSE:601216) and Inner Mongolia Junzheng Chemical Co., Ltd. Chubb Tempest Reinsurance Limited signed an equity transfer agreement to acquire an additional 15.3% stake in Huatai Insurance Group Co., Ltd. from Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. (SHSE:601216) and Inner Mongolia Junzheng Chemical Co., Ltd. for CNY 7.4 billion on November 25, 2019. Chubb Tempest Reinsurance will acquire 616 million shares for CNY 12 each with 472 million from Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. and 143 million from Inner Mongolia Junzheng Chemical Co., Ltd. Upon completion of the transaction, Chubb Limited (NYSE:CB), parent of Chubb Tempest Reinsurance Limited is expected to own 46.2% of Huatai Insurance Group. In a related transaction, Chubb Tempest Reinsurance Limited signed an intent to share purchase agreement to acquire 7.05% stake in Huatai Insurance Group Co., Ltd. from Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. and Inner Mongolia Junzheng Chemical Co., Ltd. for CNY 3.4 billion on November 25, 2019.
As of December 31, 2018, Huatai Insurance Group reported total assets of CNY 46.8 billion and net assets of CNY 14 billion. For the year ended December 31, 2018, Huatai Insurance Group reported revenue of CNY 14.5 billion and net income of CNY 523.7 million. The transaction is subject to Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd.’s shareholders’ approval, regulatory approval by the China Banking and Insurance Regulatory Commission and other important conditions. The transaction has been approved at the 32nd meeting of the 4th directorate of the Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. Effective November 26, 2019, The china Banking and Insurance Regulatory Commission approved the transaction.
Transaction is expected to be completed by the end of 2021. UBS acted as a financial advisor to Chubb Tempest Reinsurance Limited. George Yu, Elsie Shi, Elizabieth Lan Lan, Eunice Mao, Vicky Wei of Jincheng Tongda & Neal acted as legal advisors for Chubb Tempest.
Chubb Tempest Reinsurance Limited completed the acquisition of an additional 15.3% stake in Huatai Insurance Group Co., Ltd. from Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. (SHSE:601216) and Inner Mongolia Junzheng Chemical Co., Ltd. on July 13, 2020. Announcement • Jul 10
Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Inner Mongolia Junzheng Energy & Chemical Group Co.,Ltd. announced that they will report first half, 2020 results on Aug 28, 2020